Cost Effectiveness Analysis of Critical Care in Resource Limited Setting

NCT ID: NCT02556476

Last Updated: 2015-09-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

148 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-06-30

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to examine the cost effectiveness of critical care in a middle income country with limited resources.

The main study hypothesis was that critical care is cost effective in low resources setting.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators objective was to calculate the cost effectiveness of treatment of critically ill patients in a medical ICU of a middle income country with limited access to ICU resources.

Methods: Consecutive critically ill medical patients treated in a recently established medical ICU in Sarajevo, Bosnia and Herzegovina, were prospectively recorded and a subsequent cost utility analysis of intensive care in comparison to hospital ward treatment from the perspective of health care system was performed. Incremental cost effectiveness was calculated using estimates of ICU versus non-ICU treatment effectiveness based on a formal systematic review of published studies. Decision analytic modeling was used to compare treatment alternatives. Sensitivity analyses of the key model parameters were performed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ICU patients

The actual cohort of 148 critically ill medical patients that received the treatment in the intensive care unit (ICU). The interventions include interventions that are usually performed within the ICU such as mechanical ventilation, non-invasive ventilation, neuromuscular blockade, renal replacement therapy.

mechanical ventilation

Intervention Type PROCEDURE

ventilator support for the patients presenting with acute respiratory failure

neuromuscular blockade

Intervention Type PROCEDURE

paralysis of the skeletal muscles in order to optimize mechanical ventilation, especially during ARDS

renal replacement therapy

Intervention Type PROCEDURE

the procedures used to treat acute kidney injury

non-invasive ventilation

Intervention Type PROCEDURE

Procedure used for ventilation support in patients with congestive heart failure, pulmonary edema, COPD and some other conditions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

mechanical ventilation

ventilator support for the patients presenting with acute respiratory failure

Intervention Type PROCEDURE

neuromuscular blockade

paralysis of the skeletal muscles in order to optimize mechanical ventilation, especially during ARDS

Intervention Type PROCEDURE

renal replacement therapy

the procedures used to treat acute kidney injury

Intervention Type PROCEDURE

non-invasive ventilation

Procedure used for ventilation support in patients with congestive heart failure, pulmonary edema, COPD and some other conditions.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ventilator neuromuscular block continuous hemofiltration (CHF) or hemodiafiltration (CHDF) continuous positive airway pressure (CPAP)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients treated between June 1 2011 and June 29 2012 in the medical ICU

Exclusion Criteria

* Patients who stayed in the ICU less than 24 hours and
* hospital readmissions
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Sarajevo

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hajrunisa Cubro

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hajrunisa Cubro, MD

Role: PRINCIPAL_INVESTIGATOR

Medical ICU University of Sarajevo Clinical Center, Sarajevo, Bosnia and Herzegovina

Ognjen Gajic, MD, MSc

Role: STUDY_CHAIR

Division of Pulmonary and Critical Care Mayo Clinic Rochester MN USA

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CCUS-2435/11

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Intensive Care Unit Risk Score
NCT04661735 RECRUITING